Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria

NCT00130208 is registered in ClinicalTrials.gov with Keryx Biopharmaceuticals as lead sponsor.

NCT NCT00130208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00130208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Lead sponsor
Keryx Biopharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2005
Completion date
February 29, 2008
Enrollment
1,056 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy